Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la Base de données des annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Magnesium citrate cathartics III SEP / 98
Magnesium glutamate hydrobromideF1 I SEP / 98
Magnesium salicylate except oral dosage forms which also contain choline salicylate III SEP / 98
Magnesium sulfate for parenteral use II SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition I JAN / 03
Manganese and its salts in injectable form for parenteral nutrition I JAN / 03
Mannitol and its salts II SEP / 98
Maprotiline and its saltsF1 I SEP / 98
MaravirocF1 I MAY / 09
Marbofloxacin and its salts and derivativesF1 I MAR / 01
Maropitant or its saltsPDL I DEC / 13
Mazindol and its saltsTS I SEP / 98
Measles vaccine II DEC / 98
MebendazoleF2 I SEP / 98
MebolazineC3 I JUN / 02
Mecamylamine and its saltsF1 I SEP / 98
Mechlorethamine and its saltsF1 I SEP / 98
Meclizine and its saltsF2

when sold in concentrations greater than 25 mg per dosage unit

I JUL / 00
Meclizine and its salts.

when sold in concentrations of 25 mg or less per dosage unit

III MAY / 00
Meclofenamic acid and its saltsF1 I SEP / 98
Mecloqualone and any salt thereofC5 I JAN / 03
MedazepamTS I JUN / 02
Medetomidine and its saltsF1 I MAY / 04
Mefenamic acid and its saltsF1 I SEP / 98
MefenorexTS I JUN / 02
Mefloquine and its salts and derivativesF1 I SEP / 98
Megestrol and its saltsF1 I SEP / 98
Melanoma therapeutic vaccineF1 I MAR / 01
Melarsomine and its saltsF1 when sold for the treatment of heartworm in dogs I MAY / 04
Meloxicam and its salts and derivativesF1 I OCT / 03
MelphalanF1 I SEP / 98
Memantine and its saltsF1 I SEP / 06
Meningococcus vaccine II MAR / 01
MenotropinsF1 human I SEP / 98
Mepacrine and its saltsF1 I SEP / 98
Mepazine and its saltsF1 I SEP / 98
MephenoxaloneF1 I SEP / 98
Mephentermine and its saltsF1 I SEP / 98
MephobarbitalC2 I JUN / 02
Mepivacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Mepivacaine and its salts for ophthalmic or parenteral use II SEP / 98
MepolizumabPDL I AUG / 16
MeprobamateTS I SEP / 98
Mepyramine see pyrilamine U
MercaptopurineF1 I SEP / 98
Meropenem or its salts or derivativesPDL

including but not limited to doripenem

I DEC / 13
MesaboloneC3 I JUN / 02
MesnaF1 I SEP / 98
Mesocarb and any salt thereofC4 I JAN / 03
Mesoridazine and its saltsF1 I SEP / 98
MesteroloneC3 I JUN / 02
MetaldehydeF1 I SEP / 98
MetandienoneC3 I JUN / 02
Metaraminol bitartrate I SEP / 98
Metathoheptazine and its salts II SEP / 98
MetazocineN I JUN / 02
MetenoloneC3 I JUN / 02
Metformin and its salts and derivativesF1 I SEP / 98
MethabarbitalC2 I JUN / 02
Methacholine and its saltsF1 I SEP / 98
MethadoneN I JUN / 02
MethamphetamineC1 I JUN / 02
MethandriolC3 I JUN / 02
Methantheline and its salts II SEP / 98
MethaqualoneC1 I JUN / 02
Methazolamide and its saltsF1 I MAY / 00
Methdilazine and its salts II SEP / 98
Methenamine and its salts except for topical use II SEP / 98
Metheptazine and its salts II SEP / 98
MethimazoleF1 I SEP / 98
MethisazoneF1 I SEP / 98
Methocarbamol for parenteral use II SEP / 98
Methocarbamol. except for parenteral use III SEP / 98
MethoinF1 Mephenytoin and its salts I SEP / 98
Methotrexate and its saltsF1 I SEP / 98
Methotrimeprazine and its saltsF1 I SEP / 98
Methoxamine and its saltsF1 I SEP / 98
MethoxsalenF1 I SEP / 98
Methoxy polyethylene glycol-epoetin betaF1 I OCT / 09
Methyl salicylate in liquid dosage forms in concentrations greater than 30% II SEP / 98
Methyl salicylate. in liquid dosage forms in concentrations up to and including 30% U
MethyldesorphineN I JUN / 02
MethyldihydromorphineN I JUN / 02
Methyldopa and its saltsF1 I SEP / 98
Methylene Blue for parenteral use II SEP / 98
MethylparafynolF1 I SEP / 98
MethylphenidateC1 I JUN / 02
MethylphenobarbitalC2 I JUN / 02
MethylphenylisonipecotonitrileN I JUN / 02
MethyltestosteroneC3 I JUN / 02
MethyprylonTS I SEP / 98
Methysergide and its salts and derivativesF1 I SEP / 98
MetoclopramideF1 I SEP / 98
Metolazone and its saltsF1 I SEP / 98
Metomidate and its saltsF1 I SEP / 98
Metopimazine and its saltsF1 I SEP / 98
MetoponN I JUN / 02
Metoprolol and its saltsF1 I SEP / 98
MetriboloneC3 I JUN / 02
MetronidazoleF1 I SEP / 98

141 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled